Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction

Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction

US Patent 6593313 · Granted Jul 15, 2003

Estimated economic value: $1,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose topiramate/phentermine composition and methods of use thereof2015
Escalating dosing regimen for effecting weight loss and treating obesity2015
Escalating dosing regimen for effecting weight loss and treating obesity2014
Low dose topiramate/phentermine composition and methods of use thereof2014
Low dose topiramate/phentermine composition and methods of use thereof2013
Escalating dosing regimen for effecting weight loss and treating obesity2013
Treatment of pulmonary hypertension with carbonic anhydrase inhibitors2013
Treatment of pulmonary hypertension with carbonic anhydrase inhibitors2011
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide ag2007
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide ag2007
As-needed administration of tricyclic and other non-SRI antidepressant drugs to 2005
As-needed administration of tricyclic and other non-SRI antidepressant drugs to 2005